Trabectedin use in soft‐tissue sarcoma patients in a real‐world setting: Data from an Italian national drug‐access registry

Trabectedin is a marine‐derived anticancer drug approved for the treatment of patients with advanced soft‐tissue sarcomas (STS). Here, we aimed to analyze its use in a large cohort of STS patients treated in Italy in a real‐world setting. Data on STS patients treated with trabectedin in Italy were p...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincenzi, Bruno, Napolitano, Andrea, Comandone, Alessandro, Sanfilippo, Roberta, Celant, Simone, Olimpieri, Pier P., Di Segni, Susanna, Russo, Pierluigi, Casali, Paolo G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Cancer Therapy and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092104/
https://www.ncbi.nlm.nih.gov/pubmed/36196483
http://dx.doi.org/10.1002/ijc.34309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092104/
https://www.ncbi.nlm.nih.gov/pubmed/36196483
http://dx.doi.org/10.1002/ijc.34309

Ejemplares similares